5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.75▼ | 1.76▼ | 1.77▼ | 1.74▲ | 1.56▲ |
MA10 | 1.75▼ | 1.79▼ | 1.78▼ | 1.65▲ | 1.38▲ |
MA20 | 1.77▼ | 1.79▼ | 1.79▼ | 1.57▲ | 1.36▲ |
MA50 | 1.79▼ | 1.77▼ | 1.72▲ | 1.33▲ | 2.21▼ |
MA100 | 1.79▼ | 1.72▲ | 1.60▲ | 1.36▲ | 3.43▼ |
MA200 | 1.76▼ | 1.61▲ | 1.48▲ | 1.99▼ | 5.37▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.002▼ | -0.010▼ | -0.011▼ | 0.020▲ | 0.126▲ |
RSI | 33.927▼ | 39.893▼ | 47.205▼ | 64.240▲ | 52.562▲ |
STOCH | 27.500 | 20.899 | 34.868 | 78.357 | 77.791 |
WILL %R | -100.000▼ | -100.000▼ | -73.333 | -28.205 | -15.500▲ |
CCI | -62.780 | -108.998▼ | -91.561 | 92.605 | 181.497▲ |
CDL | $PDSB Doji Candlestick Pattern Detected | Set Alert |
Thursday, June 12, 2025 04:51 PM
PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers ...
|
Friday, May 23, 2025 07:55 AM
PDS Biotechnology Corporation (NASDAQ:PDSB) unveiled compelling new data on its Versamune HPV (PDS0101) immunotherapy at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting. The ...
|
Thursday, May 15, 2025 05:44 AM
PDS Biotechnology Corporation (NASDAQ:PDSB) Q1 2025 Earnings Call Transcript May 14, 2025 PDS Biotechnology Corporation beats earnings expectations. Reported EPS is $-0.21, expectations were $-0.25.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 1.76 | 1.83 | 1.74 | 1.75 | 332,198 |
12/06/25 | 1.75 | 1.85 | 1.695 | 1.79 | 716,528 |
11/06/25 | 1.68 | 1.915 | 1.68 | 1.75 | 909,442 |
10/06/25 | 1.72 | 1.765 | 1.665 | 1.68 | 571,461 |
09/06/25 | 1.74 | 1.75 | 1.66 | 1.71 | 405,090 |
06/06/25 | 1.58 | 1.76 | 1.58 | 1.69 | 914,725 |
05/06/25 | 1.64 | 1.6599 | 1.56 | 1.56 | 396,661 |
04/06/25 | 1.53 | 1.68 | 1.53 | 1.65 | 829,572 |
03/06/25 | 1.45 | 1.53 | 1.38 | 1.53 | 771,049 |
02/06/25 | 1.43 | 1.54 | 1.40 | 1.41 | 896,085 |
|
|
||||
|
|
||||
|
|